The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate-Specific Antigen Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Immunoassay
1.2.3 Timely Test Kits
1.3 Market by Application
1.3.1 Global Prostate-Specific Antigen Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Diagnostic Laboratory
1.3.4 Specialty Clinic
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate-Specific Antigen Testing Market Perspective (2018-2029)
2.2 Prostate-Specific Antigen Testing Growth Trends by Region
2.2.1 Global Prostate-Specific Antigen Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Prostate-Specific Antigen Testing Historic Market Size by Region (2018-2023)
2.2.3 Prostate-Specific Antigen Testing Forecasted Market Size by Region (2024-2029)
2.3 Prostate-Specific Antigen Testing Market Dynamics
2.3.1 Prostate-Specific Antigen Testing Industry Trends
2.3.2 Prostate-Specific Antigen Testing Market Drivers
2.3.3 Prostate-Specific Antigen Testing Market Challenges
2.3.4 Prostate-Specific Antigen Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate-Specific Antigen Testing Players by Revenue
3.1.1 Global Top Prostate-Specific Antigen Testing Players by Revenue (2018-2023)
3.1.2 Global Prostate-Specific Antigen Testing Revenue Market Share by Players (2018-2023)
3.2 Global Prostate-Specific Antigen Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate-Specific Antigen Testing Revenue
3.4 Global Prostate-Specific Antigen Testing Market Concentration Ratio
3.4.1 Global Prostate-Specific Antigen Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate-Specific Antigen Testing Revenue in 2022
3.5 Prostate-Specific Antigen Testing Key Players Head office and Area Served
3.6 Key Players Prostate-Specific Antigen Testing Product Solution and Service
3.7 Date of Enter into Prostate-Specific Antigen Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate-Specific Antigen Testing Breakdown Data by Type
4.1 Global Prostate-Specific Antigen Testing Historic Market Size by Type (2018-2023)
4.2 Global Prostate-Specific Antigen Testing Forecasted Market Size by Type (2024-2029)
5 Prostate-Specific Antigen Testing Breakdown Data by Application
5.1 Global Prostate-Specific Antigen Testing Historic Market Size by Application (2018-2023)
5.2 Global Prostate-Specific Antigen Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Prostate-Specific Antigen Testing Market Size (2018-2029)
6.2 North America Prostate-Specific Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Prostate-Specific Antigen Testing Market Size by Country (2018-2023)
6.4 North America Prostate-Specific Antigen Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate-Specific Antigen Testing Market Size (2018-2029)
7.2 Europe Prostate-Specific Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Prostate-Specific Antigen Testing Market Size by Country (2018-2023)
7.4 Europe Prostate-Specific Antigen Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate-Specific Antigen Testing Market Size (2018-2029)
8.2 Asia-Pacific Prostate-Specific Antigen Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Prostate-Specific Antigen Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Prostate-Specific Antigen Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate-Specific Antigen Testing Market Size (2018-2029)
9.2 Latin America Prostate-Specific Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Prostate-Specific Antigen Testing Market Size by Country (2018-2023)
9.4 Latin America Prostate-Specific Antigen Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate-Specific Antigen Testing Market Size (2018-2029)
10.2 Middle East & Africa Prostate-Specific Antigen Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Prostate-Specific Antigen Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Prostate-Specific Antigen Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Xiamen Biotime Biotechnology Co., Ltd.
11.1.1 Xiamen Biotime Biotechnology Co., Ltd. Company Detail
11.1.2 Xiamen Biotime Biotechnology Co., Ltd. Business Overview
11.1.3 Xiamen Biotime Biotechnology Co., Ltd. Prostate-Specific Antigen Testing Introduction
11.1.4 Xiamen Biotime Biotechnology Co., Ltd. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.1.5 Xiamen Biotime Biotechnology Co., Ltd. Recent Development
11.2 HWTAi,
11.2.1 HWTAi, Company Detail
11.2.2 HWTAi, Business Overview
11.2.3 HWTAi, Prostate-Specific Antigen Testing Introduction
11.2.4 HWTAi, Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.2.5 HWTAi, Recent Development
11.3 OptiBio Co., Ltd
11.3.1 OptiBio Co., Ltd Company Detail
11.3.2 OptiBio Co., Ltd Business Overview
11.3.3 OptiBio Co., Ltd Prostate-Specific Antigen Testing Introduction
11.3.4 OptiBio Co., Ltd Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.3.5 OptiBio Co., Ltd Recent Development
11.4 Jiangsu MicroDiag Biomedicine Technology Co.,Ltd.
11.4.1 Jiangsu MicroDiag Biomedicine Technology Co.,Ltd. Company Detail
11.4.2 Jiangsu MicroDiag Biomedicine Technology Co.,Ltd. Business Overview
11.4.3 Jiangsu MicroDiag Biomedicine Technology Co.,Ltd. Prostate-Specific Antigen Testing Introduction
11.4.4 Jiangsu MicroDiag Biomedicine Technology Co.,Ltd. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.4.5 Jiangsu MicroDiag Biomedicine Technology Co.,Ltd. Recent Development
11.5 Beijing Hotgen Biotechn Co., Ltd
11.5.1 Beijing Hotgen Biotechn Co., Ltd Company Detail
11.5.2 Beijing Hotgen Biotechn Co., Ltd Business Overview
11.5.3 Beijing Hotgen Biotechn Co., Ltd Prostate-Specific Antigen Testing Introduction
11.5.4 Beijing Hotgen Biotechn Co., Ltd Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.5.5 Beijing Hotgen Biotechn Co., Ltd Recent Development
11.6 Humasis,AccuquikTMTest Kits
11.6.1 Humasis,AccuquikTMTest Kits Company Detail
11.6.2 Humasis,AccuquikTMTest Kits Business Overview
11.6.3 Humasis,AccuquikTMTest Kits Prostate-Specific Antigen Testing Introduction
11.6.4 Humasis,AccuquikTMTest Kits Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.6.5 Humasis,AccuquikTMTest Kits Recent Development
11.7 CTK Biotech, Inc.
11.7.1 CTK Biotech, Inc. Company Detail
11.7.2 CTK Biotech, Inc. Business Overview
11.7.3 CTK Biotech, Inc. Prostate-Specific Antigen Testing Introduction
11.7.4 CTK Biotech, Inc. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.7.5 CTK Biotech, Inc. Recent Development
11.8 INTEC
11.8.1 INTEC Company Detail
11.8.2 INTEC Business Overview
11.8.3 INTEC Prostate-Specific Antigen Testing Introduction
11.8.4 INTEC Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.8.5 INTEC Recent Development
11.9 XIAMEN BOSON BIOTECH CO.,LTD
11.9.1 XIAMEN BOSON BIOTECH CO.,LTD Company Detail
11.9.2 XIAMEN BOSON BIOTECH CO.,LTD Business Overview
11.9.3 XIAMEN BOSON BIOTECH CO.,LTD Prostate-Specific Antigen Testing Introduction
11.9.4 XIAMEN BOSON BIOTECH CO.,LTD Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.9.5 XIAMEN BOSON BIOTECH CO.,LTD Recent Development
11.10 AccuBioTech Co, Ltd.
11.10.1 AccuBioTech Co, Ltd. Company Detail
11.10.2 AccuBioTech Co, Ltd. Business Overview
11.10.3 AccuBioTech Co, Ltd. Prostate-Specific Antigen Testing Introduction
11.10.4 AccuBioTech Co, Ltd. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.10.5 AccuBioTech Co, Ltd. Recent Development
11.11 Bio-Rad Laboratories, Inc.
11.11.1 Bio-Rad Laboratories, Inc. Company Detail
11.11.2 Bio-Rad Laboratories, Inc. Business Overview
11.11.3 Bio-Rad Laboratories, Inc. Prostate-Specific Antigen Testing Introduction
11.11.4 Bio-Rad Laboratories, Inc. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.11.5 Bio-Rad Laboratories, Inc. Recent Development
11.12 Accuquik Test Kits
11.12.1 Accuquik Test Kits Company Detail
11.12.2 Accuquik Test Kits Business Overview
11.12.3 Accuquik Test Kits Prostate-Specific Antigen Testing Introduction
11.12.4 Accuquik Test Kits Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.12.5 Accuquik Test Kits Recent Development
11.13 OPKO Health, Inc.
11.13.1 OPKO Health, Inc. Company Detail
11.13.2 OPKO Health, Inc. Business Overview
11.13.3 OPKO Health, Inc. Prostate-Specific Antigen Testing Introduction
11.13.4 OPKO Health, Inc. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.13.5 OPKO Health, Inc. Recent Development
11.14 bioMérieux SA
11.14.1 bioMérieux SA Company Detail
11.14.2 bioMérieux SA Business Overview
11.14.3 bioMérieux SA Prostate-Specific Antigen Testing Introduction
11.14.4 bioMérieux SA Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.14.5 bioMérieux SA Recent Development
11.15 Beckman Coulter, Inc.
11.15.1 Beckman Coulter, Inc. Company Detail
11.15.2 Beckman Coulter, Inc. Business Overview
11.15.3 Beckman Coulter, Inc. Prostate-Specific Antigen Testing Introduction
11.15.4 Beckman Coulter, Inc. Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.15.5 Beckman Coulter, Inc. Recent Development
11.16 Abbott
11.16.1 Abbott Company Detail
11.16.2 Abbott Business Overview
11.16.3 Abbott Prostate-Specific Antigen Testing Introduction
11.16.4 Abbott Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.16.5 Abbott Recent Development
11.17 Siemens Healthcare
11.17.1 Siemens Healthcare Company Detail
11.17.2 Siemens Healthcare Business Overview
11.17.3 Siemens Healthcare Prostate-Specific Antigen Testing Introduction
11.17.4 Siemens Healthcare Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.17.5 Siemens Healthcare Recent Development
11.18 DiaSorin
11.18.1 DiaSorin Company Detail
11.18.2 DiaSorin Business Overview
11.18.3 DiaSorin Prostate-Specific Antigen Testing Introduction
11.18.4 DiaSorin Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.18.5 DiaSorin Recent Development
11.19 F.Hoffmann-La Roche Ltd
11.19.1 F.Hoffmann-La Roche Ltd Company Detail
11.19.2 F.Hoffmann-La Roche Ltd Business Overview
11.19.3 F.Hoffmann-La Roche Ltd Prostate-Specific Antigen Testing Introduction
11.19.4 F.Hoffmann-La Roche Ltd Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.19.5 F.Hoffmann-La Roche Ltd Recent Development
11.20 Mediwatch (LABORIE)
11.20.1 Mediwatch (LABORIE) Company Detail
11.20.2 Mediwatch (LABORIE) Business Overview
11.20.3 Mediwatch (LABORIE) Prostate-Specific Antigen Testing Introduction
11.20.4 Mediwatch (LABORIE) Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.20.5 Mediwatch (LABORIE) Recent Development
11.21 BodiTech
11.21.1 BodiTech Company Detail
11.21.2 BodiTech Business Overview
11.21.3 BodiTech Prostate-Specific Antigen Testing Introduction
11.21.4 BodiTech Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.21.5 BodiTech Recent Development
11.22 Bristol-Myers Squibb Company
11.22.1 Bristol-Myers Squibb Company Company Detail
11.22.2 Bristol-Myers Squibb Company Business Overview
11.22.3 Bristol-Myers Squibb Company Prostate-Specific Antigen Testing Introduction
11.22.4 Bristol-Myers Squibb Company Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.22.5 Bristol-Myers Squibb Company Recent Development
11.23 GE Healthcare
11.23.1 GE Healthcare Company Detail
11.23.2 GE Healthcare Business Overview
11.23.3 GE Healthcare Prostate-Specific Antigen Testing Introduction
11.23.4 GE Healthcare Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.23.5 GE Healthcare Recent Development
11.24 Endocare
11.24.1 Endocare Company Detail
11.24.2 Endocare Business Overview
11.24.3 Endocare Prostate-Specific Antigen Testing Introduction
11.24.4 Endocare Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.24.5 Endocare Recent Development
11.25 GlaxoSmithKline
11.25.1 GlaxoSmithKline Company Detail
11.25.2 GlaxoSmithKline Business Overview
11.25.3 GlaxoSmithKline Prostate-Specific Antigen Testing Introduction
11.25.4 GlaxoSmithKline Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.25.5 GlaxoSmithKline Recent Development
11.26 Anixa Biosciences
11.26.1 Anixa Biosciences Company Detail
11.26.2 Anixa Biosciences Business Overview
11.26.3 Anixa Biosciences Prostate-Specific Antigen Testing Introduction
11.26.4 Anixa Biosciences Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.26.5 Anixa Biosciences Recent Development
11.27 Ortho Clinical
11.27.1 Ortho Clinical Company Detail
11.27.2 Ortho Clinical Business Overview
11.27.3 Ortho Clinical Prostate-Specific Antigen Testing Introduction
11.27.4 Ortho Clinical Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.27.5 Ortho Clinical Recent Development
11.28 Fujirebio
11.28.1 Fujirebio Company Detail
11.28.2 Fujirebio Business Overview
11.28.3 Fujirebio Prostate-Specific Antigen Testing Introduction
11.28.4 Fujirebio Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.28.5 Fujirebio Recent Development
11.29 Pharmacia Delfia
11.29.1 Pharmacia Delfia Company Detail
11.29.2 Pharmacia Delfia Business Overview
11.29.3 Pharmacia Delfia Prostate-Specific Antigen Testing Introduction
11.29.4 Pharmacia Delfia Revenue in Prostate-Specific Antigen Testing Business (2018-2023)
11.29.5 Pharmacia Delfia Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details